Nielsen, M. M., Tolbod, L. P., Borre, M., Høyer, S., Harms, H. J., Sørensen, J., Frøkiær, J. & Borghammer, P. (2019).
The relationship between tumor aggressiveness and cholinergic PET imaging in prostate cancer tissue. A proof-of-concept study.
American Journal of Nuclear Medicine and Molecular Imaging,
9(3), 185-192.
Sierra-Parraga, J. M., Munk, A., Schmidt Andersen, C., Lohmann, S., Moers, C., Baan, C. C., Ploeg, R., Pool, M.
, Krarup Keller, A., Møller, B., Leuvenink, H., Hoogduijn, M. J.
, Jespersen, B. & Eijken, M. (2019).
Mesenchymal stromal cells are retained in the porcine renal cortex independently of their metabolic state after renal intra-arterial infusion.
Stem Cells and Development,
28(18), 1224-1235.
https://doi.org/10.1089/scd.2019.0105
Garnon, J., Van Strijen, M. J.
, Nielsen, T. K., King, A. J., Montauban Van Swijndregt, A. D., Cazzato, R. L., Auloge, P., Rousseau, C., Dalili, D., Keeley, F. X., Lagerveld, B. W. & Breen, D. J. (2019).
Safety of percutaneous renal cryoablation: an international multicentre experience from the EuRECA retrospective percutaneous database.
European Radiology,
29(11), 6293-6299.
https://doi.org/10.1007/s00330-019-06191-yJochumsen, M. R., Bouchelouche, K., Nielsen, K. B., Frøkiær, J., Borre, M., Sørensen, J. & Tolbod, L. P. (2019).
Repeatability of tumor blood flow quantification with 82Rubidium-PET/CT in prostate cancer - a test-retest study.
EJNMMI Research,
9(58), Article 58.
https://doi.org/10.1186/s13550-019-0529-2
Jochumsen, M. R., Bouchelouche, K., Borre, M., Frøkiær, J., Sørensen, J. & Tolbod, L. P. (2019).
Repeatability of static 82Rubidium PET for tumor blood flow imaging in prostate cancer - a test-retest study. Poster session presented at Society of Nuclear Medicine and Molecular Imaging: Annual Meeting 2019, Anaheim, California, United States.
Gulley, J. L.
, Borre, M., Vogelzang, N. J., Ng, S., Agarwal, N., Parker, C. C., Pook, D. W., Rathenborg, P., Flaig, T. W., Carles, J., Saad, F., Shore, N. D., Chen, L., Heery, C. R., Gerritsen, W. R., Priou, F.
, Langkilde, N. C., Novikov, A. & Kantoff, P. W. (2019).
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
37(13), 1051-1061.
https://doi.org/10.1200/JCO.18.02031Christensen, E., Birkenkamp-Demtröder, K., Sethi, H., Shchegrova, S., Salari, R.
, Nordentoft, I., Wu, H.-T.
, Knudsen, M., Lamy, P., Lindskrog, S. V., Taber, A., Balcioglu, M.
, Vang, S., Assaf, Z., Sharma, S., Tin, A. S., Srinivasan, R., Hafez, D.
, Reinert, T. ... Dyrskjøt, L. (2019).
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.
Journal of Clinical Oncology,
37(18), 1547-1557.
https://doi.org/10.1200/JCO.18.02052
Kjaer, T. K., Andersen, E. A. W.
, Winther, J. F., Bidstrup, P. E.
, Borre, M., Møller, H., Larsen, S. B., Johansen, C. & Dalton, S. O. (2019).
Long-term Somatic Disease Risk in Adult Danish Cancer Survivors.
JAMA Oncology,
5(4), 537-545.
https://doi.org/10.1001/jamaoncol.2018.7192Villumsen, B. R., Jorgensen, M. G.
, Frystyk, J., Hordam, B.
& Borre, M. (2019).
Home-based ‘exergaming’ was safe and significantly improved 6-min walking distance in patients with prostate cancer: a single-blinded randomised controlled trial.
BJU International,
124(4), 600-608.
https://doi.org/10.1111/bju.14782
Ernst, A., Lauridsen, L. L. B., Brix, N., Arah, O. A.
, Olsen, J., Olsen, L. H. & Ramlau-Hansen, C. H. (2019).
Parental time to pregnancy, medically assisted reproduction and pubertal development in boys and girls.
Human Reproduction,
34(4), 724-732.
https://doi.org/10.1093/humrep/dez008
Tombal, B.
, Borre, M., Rathenborg, P., Werbrouck, P., Van Poppel, H., Heidenreich, A., Iversen, P., Braeckman, J., Heracek, J., Baron, B., Krivoshik, A., Hirmand, M. & Smith, M. R. (2018).
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results.
Journal of Urology,
199(2), 459-464.
https://doi.org/10.1016/j.juro.2017.08.103Bjerre, M. T., Strand, S. H., Nørgaard, M., Kristensen, H., Rasmussen, A. K.
, Mortensen, M. M., Fredsøe, J., Mouritzen, P.
, Ulhøi, B., Ørntoft, T., Borre, M. & Sørensen, K. D. (2019).
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer.
International Journal of Molecular Sciences ,
20(5), Article 1173.
https://doi.org/10.3390/ijms20051173
Bjerre, E. D., Brasso, K., Jørgensen, A. B., Petersen, T. H., Eriksen, A. R., Tolver, A., Christensen, J. F., Poulsen, M. H.
, Madsen, S. S., Østergren, P. B.
, Borre, M., Krustrup, P., Johansen, C., Rørth, M. & Midtgaard, J. (2019).
Football Compared with Usual Care in Men with Prostate Cancer (FC Prostate Community Trial): A Pragmatic Multicentre Randomized Controlled Trial.
Sports Medicine,
49(1), 145-158.
https://doi.org/10.1007/s40279-018-1031-0Rodríguez-Socarrás, M., Vasquez, J. L., Uvin, P.
, Skjold-Kingo, P. & Rivas, J. G. (2018).
“Síndrome de agotamiento”: Estrés, burnout y depresión en urología.
Archivos Espanoles de Urologia,
71(1), 46-54.
Fredsøe, J., Rasmussen, A. K. I., Mouritzen, P.
, Borre, M., Ørntoft, T. & Sørensen, K. D. (2019).
A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine.
International Journal of Cancer,
145(9), 2558-2567.
https://doi.org/10.1002/ijc.32296
Oedorf, K., Skaaheim Haug, E., Liedberg, F., Järvinen, R.
, Bjerggaard Jensen, J., Arum, C.-J. R. & Wrist Lam, G. (2019).
Perioperative management of radical cystectomy in the Nordic countries.
Scandinavian Journal of Urology,
53(1), 51-55.
https://doi.org/10.1080/21681805.2019.1583686Azawi, N. H., Rohrsted, M., Poulsen, J., Lund, L., Kromann-Andersen, B.
& Olsen, L. H. (2019).
Robotic versus laparoscopic urological surgery: incidence of reoperation and complications.
Scandinavian Journal of Urology,
53(1), 56-61.
https://doi.org/10.1080/21681805.2019.1588918